Effects of MP-AzeFlu enhanced by activation of bitter taste receptor TAS2R

Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology
Sandra EkstedtLars Olaf Cardell

Abstract

MP-AzeFlu is relatively new a pharmaceutical drug used in the treatment of allergic rhinitis. It is comprised of azelastine hydrochloride (AZE), a potent histamine-H1-receptor antagonist and fluticasone propionate (FP), corticosteroid. It's somewhat bitter taste (often considered a disadvantage) can be attributed to AZE. We here hypothesize that MP-AzeFlu may induce some of its beneficial effects through activation of bitter taste receptors (Tas2R), which have recently been described in human airways. In the nose Tas2Rs induce secretion of antimicrobial peptides and increase ciliary activity, while in the lung they cause airway smooth muscle relaxation. The mechanisms behind Tas2R-mediated effects are not yet fully known. In order to evaluate the role of Tas2R in the effects induced by MP-AzeFlu the dilatory response of pre-contracted isolated airways from Balb/c mice was investigated in tissue bath myographs in the presence or absence of various well-characterized pharmacological antagonists or their corresponding vehicles. MP-AzeFlu caused a potent dose-dependent relaxation of pre-contracted airways, an effect probably mediated by its AZE component. The dilatory effect of MP-AzeFlu and AZE both mimicked the response induced b...Continue Reading

References

Sep 25, 2010·Results and Problems in Cell Differentiation·Maik Behrens, Wolfgang Meyerhof
Sep 11, 2012·American Journal of Physiology. Lung Cellular and Molecular Physiology·Ville PulkkinenSven-Erik Dahlén
May 9, 2013·International Archives of Allergy and Immunology·Eli MeltzerJean Bousquet
Apr 24, 2014·The Journal of Allergy and Clinical Immunology·Maria EkoffSven-Erik Dahlén
Dec 25, 2016·Molecular and Cellular Biochemistry·Appalaraju JaggupilliPrashen Chelikani
Apr 7, 2017·Biological & Pharmaceutical Bulletin·Mai SotoyamaNoriyuki Namiki
May 26, 2018·Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology·Bilal Alaskhar AlhamweDaniel P Potaczek
Dec 24, 2018·Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology·Jordi Roca-FerrerJoaquim Mullol

❮ Previous
Next ❯

Citations

Mar 9, 2021·Drug Design, Development and Therapy·Weyland ChengFangna Liu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.